InCarda CEO, Grace Colón, Discusses InRhythm™ Program and Unmet Needs for Atrial Fibrillation at Biotech Showcase 2020

InCarda Therapeutics CEO Grace Colón, PhD, meets with CG Life Managing Partner Erik Clausen at Biotech Showcase 2020 to discuss unmet needs in cardiovascular health. She provides an update on the company’s development of first-of-their-kind inhaled therapies for cardiovascular diseases, including atrial fibrillation. Dr. Colón also summarizes key takeaways from her panel session on making seed capital more accessible for early-stage companies and describes her philosophy for pursuing investment partners for InCarda.

About the Biotech Showcase

Biotech Showcase™ January 13–15, 2020, is one of the industry’s leading investor conferences expecting more than 3,500 attendees, 2,200 companies, and over 1,000 investors. Biotech Showcase™ provides a key platform where companies can showcase their innovative assets and build their profile with potential investors and strategic partners.

For more information – https://informaconnect.com/biotech-showcase/